Blueprint MedicinesBPMC 
$89.313.24%24h
3.24%24h
Global rank2611
Market cap$5.41B
Change 7d0.22%
YTD Performance-1.36%
SP500 benchmarkUnderperform
P/E-10.67
P/S21.69
Revenue$249.38M
Earnings-$506.98M
Dividend yield-
Main Sector
Healthcare
Market capitalization of Blueprint Medicines (BPMC)
As of November 2024, Blueprint Medicines has a market cap of $5.41B. This makes Blueprint Medicines the world's 2611th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Blueprint Medicines from 2015 to 2024
-
Value:-
Market cap history of Blueprint Medicines from 2015 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $5.24B | -6.22% |
| 2023 | $5.59B | 110.55% |
| 2022 | $2.65B | -59.10% |
| 2021 | $6.49B | -4.49% |
| 2020 | $6.79B | 40.00% |
| 2019 | $4.85B | 48.60% |
| 2018 | $3.26B | -28.51% |
| 2017 | $4.57B | 168.84% |
| 2016 | $1.70B | 6.49% |
| 2015 | $1.60B | - |
BPMC Market Cap Today is $5.41B 3.24% - 23 Nov 2024
View largest stocks by market cap 
